癌微小環境研究up-date『癌微小環境に基づいた乳癌治療』 CANCER BOARD of the BREAST,5:30-31 2019 Author:伊藤研一
FGF2-FGFR1 pathway activation together with thymidylate synthase upregulation is induced in pemetrexed-resistant lung cancer cells Oncotarget ,10:1171-1192 2019 Author:Miura K, Oba T, Hamanaka K, Ito K
Smoking influences the yield of dendritic cells for cancer immunotherapy Pharmaceutical Regulatory Affairs,4(1):133 2015 Author:Shimodaira S, Higuchi Y, Koya T, Kobayashi T, Yanagisawa R, Hirabayashi K, Ito K, Koizumi T, Maejima S and Udagawa N
Coexpression of EpCAM, CD44 Variant Isoforms and Claudin-7 in Anaplastic Thyroid Carcinoma PLoS One,9:e94487 2014 Author:Okada T, Nakamura T, Watanabe T, Onoda N, Ashida A, Okuyama R, Ito K
Expression of Polypeptide N-acetylgalactosaminyl Transferase-3 and its Association with Clinicopathological Factors Carcinomas Thyroid,23:1553-60 2013 Author:Mochizuki Y, Ito K, Izumi H, Kohno K, Amano J
Association of Nuclear YB-1 Localization With Lung Resistance-related Protein and Epidermal Growth Factor Receptor Expression in Lung Cancer. Clin Lung Cancer.,13(5):375-384 2012 Author:Hyogotani A, Ito K, Yoshida K, Izumi H, Kohno K, Amano J.
Multimodality therapeutic outcomes in anaplastic thyroid carcinoma: improved survival in subgroups of patients with localized primary tumors. Head Neck.,34(2):230-237 2012 Author:Ito K, Hanamura T, Murayama K, Okada T, Watanabe T, Harada M, Ito T, Koyama H, Kanai T, Maeno K, Mochizuki Y, Amano J.
Alteration of Y-box binding protein-1 expression modifies the response to endocrine therapy in estrogen receptor-positive breast cancer. Breast Cancer Res Treat.,133(1):145-159 2012 Author:Ito T, Kamijo S, Izumi H, Kohno K, Amano J, Ito K.
Mediastinal growing teratoma syndrome successfully treated by multiple modality therapies. Intern Med.,50(6):607-610 2011 Author:Agatsuma T, Koizumi T, Kubo K, Saito G, Kondo R, Yoshida K, Ito K, Endo M, Shimojo H.
Endoscopic-assisted skin-sparing mastectomy combined with sentinel node biopsy. ANZ J Surg.,78(10):894-898 2008 Author:Ito K, Kanai T, Gomi K, Watanabe T, Ito T, Komatsu A, Fujita T, Amano J.
Increased nuclear localization of transcription factor Y-box binding protein 1 accompanied by up-regulation of P-glycoprotein in breast cancer pretreated with paclitaxel CLINICAL CANCER RESEARCH,11(24):8837-8844 2005 Author:Fujita T, Ito K, Izumi H, Kimura M, Sano M, Nakagomi H, Maeno K, Hama Y, Shingu K, Tsuchiya S, Kohno K, Fujimori M
Stimulation of P19CL6 with multiple reagents induces pulsating particles in vivo CURRENT MEDICAL RESEARCH AND OPINION,21(5):795-803 2005 Author:Ohtsu Y, Johkura K, Ito K, Akashima T, Asanuma K, Ogiwara N, Oka T, Komuro I, Sasaki K, Amano J
Suppression of acute and chronic rejection by hepatocyte growth factor in a murine model of cardiac transplantation - Induction of tolerance and prevention of cardiac allograft vasculopathy CIRCULATION,110(12):1650-1657 2004 Author:Yamaura, K; Ito, K; Tsukioka, K; Wada, Y; Makiuchi, A; Sakaguchi, M; Akashima, T; Fujimori, M; Sawa, Y; Morishita, R; Matsumoto, K; Nakamura, T; Suzuki, J; Amano, J; Isobe, M
Mutation of the class I beta-tubulin gene does not predict response to paclitaxel for breast cancer CANCER LETTERS,198(1):89-97 2003 Author:Maeno K, Ito K, Hama Y, Shingu K, Kimura M, Sano M, Nakagomi H, Tsuchiya S, Fujimori M
Mutation of Trp1254 in the multispecific organic anion transporter, MRP2 (ABCC2), alters substrate specificity and results in loss of methotrexate transport activity J. Biol. Chem,276:38108-38114 2001 Author:Ito K, Oleschuk CJ, Westlake C, Vasa MZ, Deeley RG, Cole SPC
Transport of the -O-Glucuronide Conjugate of the Tobacco-specific Carcinogen 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by the Multidrug Resistance Protein 1 (MRP1). REQUIREMENT FOR GLUTATHIONE OR A NON-SULFUR-CONTAINING ANALOG J. Biol. Chem,276:27846-27854 2001 Author:E. Leslie/ K. Ito/ S. Cole
Mutation of a Single Conserved Tryptophan in Multidrug Resistance Protein 1 (MRP1/ABCC1) Results in Loss of Drug Resistance and Selective Loss of Organic Anion Transport J. Biol. Chem,276:15616-15624 2001 Author:K. Ito/ S. Cole
Clinical significance of the increased multidrug resistance-associated protein (MRP) gene expression in patients with primary breast cancer Oncol Res,10:99-109 1998 Author:K. Ito/ M. Fujimori/ J. Amano
Bilateral Synchronous Spindle Cell, Apocrine and Scirrhous Breast Cancer in a Case of Malignant Lymphoma Breast Cancer,5:411-416 1998 Author:Ito K, Kurai M, Fujimori M, Hama Y, Shingu K, Kobayashi S, Yamagami O, Matsuyama I, Tsuchiya S, Amano J
Expression of tissue-type plasminogen activator and its inhibitor couples with development of capillary network by human microvascular endothelial cells on Matrigel J. Cell. Physiol,162:213-024 1995 Author:Ito K, Ryuto M, Ushiro S, Ono M, Sugenoya A, Kuraoka A, Shibata Y, Kuwano M
研究者総覧
